left-caret
Professionals
Image: Martin Prokoph

Martin Prokoph

Partner, Corporate Department
Frankfurt
TaunusTurm - Taunustor 1
Frankfurt am Main, HE
60310
Germany

Fax: 49 69 907485-312

Overview

Martin Prokoph is a partner in the Private Equity and M&A practices at Paul Hastings and is based in the Frankfurt office. Mr. Prokoph represents private equity and corporate clients in a broad range of transactions, including leveraged buyouts, M&A, growth equity investments, corporate restructurings, joint ventures, and management incentive schemes. He has extensive experience in cross-border transactions, particularly those involving targets in the tech, pharma, and life sciences sector.

Accolades and Recognitions

  • Recognized in private equity and venture capital, JUVE AWARDS, 2020

Education

  • State of Berlin, Second State Exam, 2010

  • Deakin University (Australia), Master of International Finance, 2007

  • Humboldt-University Berlin, First State Exam, 2005

Speaking Engagements

  • Guest lecturer at Gottfried Wilhelm Leibniz University Hannover

Recent Representations

  • Nexelis Group Inc., a portfolio company of Ampersand Capital Partners, in the acquisition of the GSK vaccines clinical bioanalytical laboratory (Clinical Laboratory Science (CLS) Business) in Marburg, Germany.

  • HSRL Holdings LLC d/b/a StageBio, a portfolio company of Ampersand Capital Partners, in the acquisition of TPL Path Labs, a contract research organization (CRO) that conducts preclinical and clinical studies as a service provider in research and development of medical devices and drugs.

  • Ampersand Capital Partners in the acquisition of a majority stake in GeneWerk GmbH, a cell and gene therapy testing lab and a leading provider of vector integration site analysis.

  • Capital D in the sale of a majority stake in Invincible Brands ' premium D2C portfolio companies HelloBody, Banana Beauty, and Mermaid+Me to Henkel.

  • PCI Pharma Services, a portfolio company of Partners Group and leading provider of pharmaceutical and biopharmaceutical supply chain solutions, in the acquisition of the Bellwyck Pharma Services group.

  • Neon Therapeutics (Nasdaq: NTGN) in its acquisition by BioNTech (Nasdaq: BNTX) through an all-stock transaction by way of merger.

  • ANSYS, Inc. a global leader of engineering simulation software, in its acquisition of the Dynardo group, a leading provider of simulation process integration and design optimization (PIDO) technology headquartered in Weimar, Germany.

  • Ampersand Capital Partners in the acquisition of Vibalogics GmbH, a development and manufacturing organization providing process development and GMP manufacturing services in the virotherapy field.

  • Onapsis Inc. in its acquisition of the Virtual Forge group, a leading provider of automated security solutions for SAP.

  • Vision Ophthalmology Group, a portfolio company of Stirling Square Capital Partners, in its acquisition of M.E.D Medical Products GmbH, a leading manufacturer of customized surgical kits.

  • Capital D in the acquisition of a majority stake in Invincible Brands UG (haftungsbeschr√§nkt), a social media influencer-led D2C marketing and product development company.

  • Castlelake in various acquisitions and dispositions of real estate portfolios, including by way of a combined asset share and loan acquisition and debt-to-equity swaps.

  • Partners Group in the acquisition of a minority stake in a medical technology company.

  • Hartford Steam Boiler (HSB), a part of Munich RE, in its acquisition of relayr Inc. a Berlin-based Internet of Things (IoT) company.

  • Linxens in the acquisition of Smartrac's SIT division, a global leader in the development and manufacturing of RFID inlays and antennas.

  • Rossignol Group in the acquisition of the Felt Group, a leading bicycle manufacturer.

Languages

English
German

Admissions

Germany

Education

Humboldt University of Berlin, Faculty of Law, 2 St Exam 2010
Humboldt University of Berlin, Faculty of Law, 1 St Exam 2005

Get In Touch With Us

Contact Us